Celularity Inc.
CELU · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 138.1% | 26.7% | -15.7% | – |
| Gross Profit | $0 | $0 | -$0 | $0 |
| % Margin | 72.4% | 29.7% | -9.4% | 54.8% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -80.6% | -807.8% | -772.4% | -413% |
| Net Income | -$0 | -$0 | $0 | -$0 |
| % Margin | -106.8% | -862% | 79% | -469.3% |
| EPS Diluted | -2.645 | -11.02 | 0.947 | -14.93 |
| % Growth | 76% | -1,263.4% | 106.3% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |